BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.

Beijing Aosaikang Pharmaceutical Co., Ltd.

002755

CNE100001X92

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
9.59 ^CNY	+9.98%		+14.85%	-11.37%

Mar. 05	Beijing Aosaikang Pharma's Unit Gets Nod to Market Delafloxacin for Injection	MT
Jan. 23	Aosaikang Pharmaceutical Registers Breast Cancer Drug	MT

Beijing Aosaikang Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021

May 23, 2022 at 03:39 pm EDT

Beijing Aosaikang Pharmaceutical Co., Ltd. approved a cash dividend of CNY 1.00000000 per 10 shares (tax included) for the year 2021, at its AGM held on 20 May 2022.

Latest news about Beijing Aosaikang Pharmaceutical Co., Ltd.

Beijing Aosaikang Pharma's Unit Gets Nod to Market Delafloxacin for Injection	Mar. 05	MT
Aosaikang Pharmaceutical Registers Breast Cancer Drug	Jan. 23	MT
Aosaikang Pharmaceutical's Unit Gets Nod for Two Drugs	Jan. 17	MT
Aosaikang Pharmaceutical's Unit Gets Nod to Trial ASKC202 Tablets	Nov. 13	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Aosaikang Pharmaceutical's Unit Gets Nod to Test Gastric Cancer Drug	23-10-17	MT
Beijing Aosaikang Pharmaceutical Co., Ltd.(XSEC:002755) added to S&P Global BMI Index	23-09-18	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Aosaikang Pharma's Unit Gets Nod to Amend Instructions for Heart Drug	23-08-07	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Aosaikang Pharma Unit Registers Acid Reflux Drug in China	23-04-17	MT
Aosaikang Pharma Registers Three Drugs	23-03-24	MT
Aosaikang Pharma US Unit Gets Regulatory Nod For Anti-Tumor Drug Trial	22-12-20	MT
Beijing Aosaikang Pharmaceutical Co., Ltd.(XSEC:002755) dropped from S&P Global BMI Index	22-12-19	CI
Aosaikang Pharma Wins Nod to Market Variant of Pfizer’s Breast Cancer Drug	22-11-21	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on June 20, 2022	22-06-10	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	22-05-23	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021	22-05-05	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. cancelled the acquisition of Jiangsu Vedkang Medical Science and Technology Co., Ltd. from Changzhou Beiruishi Enterprise Management Co., Ltd., Changzhou Yisiyuan Enterprise Management Co., Ltd., Zhuang Xiaojin and Miao Donglin.	22-04-16	CI
Propella Therapeutics, Inc. Announces Licensing Agreement with Jiangsu Aosaikang Pharmaceutical Co. Ltd. for Development and Commercial Rights to CGS-200-5 in Greater China	22-04-07	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Announces Directorate Appointments	22-02-21	CI

Chart Beijing Aosaikang Pharmaceutical Co., Ltd.

Duration

Period

Chart Beijing Aosaikang Pharmaceutical Co., Ltd.

More charts

BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD., formerly Beijing New Oriental Star Petrochemical Engineering Co., Ltd., is a China-based company mainly engaged in pharmaceutical manufacturing business. The Company produces proton pump inhibitor injections through its subsidiary Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Sector

Pharmaceuticals

Calendar

2024-04-28 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.	-11.37%	1.12B
ELI LILLY AND COMPANY	+27.92%	659B
NOVO NORDISK A/S	+27.68%	557B
JOHNSON & JOHNSON	-4.59%	359B
MERCK & CO., INC.	+16.38%	322B
ABBVIE INC.	+9.39%	297B
ASTRAZENECA PLC	+6.30%	215B
NOVARTIS AG	+4.80%	210B
ROCHE HOLDING AG	-6.05%	200B
PFIZER, INC.	-8.58%	149B

Other Pharmaceuticals